Search
Displaying results 1061 to 1070 of 1202.
COVID-19: Immune system derails
Most patients infected with the coronavirus SARS-CoV-2 show mild or even no symptoms. However, 10 to 20 percent of patients develop pneumonia during the course of COVID-19 disease, some of them with life-threatening consequences. "There is still not very much known…
How many people are now immune to SARS-CoV-2?
The strategies for dealing with the COVID-19 pandemic depend largely on estimation of the actual number of infected people. In addition to the cases tested and confirmed, there is an unknown number of people who have undergone infection with or without mild symptoms and…
Exploring the RNA world of the microbiota
In the human intestine, countless bacteria form a complex community. B. theta is one of the most abundant species there and relatively easy to study in the lab. ”Until now, no fine-grained transcriptome annotation – a map of the entirety of RNA molecules – was…
Representative, nationwide coronavirus antibody study starts in Reutlingen
Mild or even asymptomatic SARS-CoV-2 infections are often not detected and thus make it difficult to estimate the infection rate. While PCR tests are only effective in the acute phase, antibody tests also permit reliable indications of COVID-19 infections that have been…
Leap forward in the fight against antibiotic resistance
"Even when growing together under the same condition individual bacteria can behave very differently," says Prof Jörg Vogel, director of the HIRI and chair of the Institute for Molecular Infection Biology at the Medical Faculty of the Julius-Maximilians-Universität in…
Mirror, mirror – New enzyme group converts amino acid into its mirror image
Professor Köhnke, you have discovered a new group of enzymes – does that happen to you often? Köhnke: (laughs) Yes and no! Our research group “Structural Biology of Biosynthetic Enzymes” is always looking for new compounds and reactions. In the course of this, we also…
Biomedical Research strengthened in Saarland through the new Leibniz Campus
Saarland’s Prime Minister, Tobias Hans, who is also responsible for the Department of Higher Education, Science and Technology in the Saarland State Chancellery, extended his congratulations on the success of the initiative: “The Leibniz Science Campus combines the…
EU funds training network for young researchers
Antimicrobial resistance is a serious global health problem and, at present, there is no collaborative inter-institutional and highly interdisciplinary training network explicitly focused on the discovery and development of novel anti-infective agents. In order to…
Start of HZI’s nationwide antibody study
In this context, the Helmholtz Centre for Infection Research (HZI) in Braunschweig is conducting a nationwide project. The MuSPAD project (Multi-local and Serial cross-sectional Prevalence Study on Antibodies against SARS-CoV-2 in Germany) aims at improving knowledge on…
Protection against the immune system
Even though a virus is currently sweeping the globe, we know that our immune system naturally protects us against most of these disease-causing intruders. Defence cells constantly patrol our tissues, looking for pathogens. Body cells that have been invaded by a virus…
